Abstract
Fungal transformation of the diterpenoid kaempulchraol E (1) by Rhizopus oryzae KX685359 afforded two trihydroxlated isopimaradienes: 2α,6β,14β-trihydroxy-isopimara-8(9),15-diene (2) and 2α,6β,14α-trihydroxy-isopimara-8(9),15-diene (3) in addition to the known metabolite roscorane B (4). Chemical structures were established by spectroscopic techniques including: HRMS, FT-IR and 1D- & 2D-NMR. The structure of 2 was confirmed by single-crystal, X-ray diffraction analysis. Bio-transformed metabolites as well as the substrate originally isolated from Kaempheria galanga were tested against two cancer cell lines: HSC-2 and B16-BL6. Compounds 4 showed greater toxicity than the original plant derived diterpene (IC50 54.08 ± 0.05 versus 96.05 ± 0.03 μM, respectively) when assayed against the HSC-2 cell line. This study confirms the role of fungal transformations in developing novel natural products with efficacious biological activities.
Author supplied keywords
Cite
CITATION STYLE
Elshamy, A. I., Abd El Aty, A. A., Yoneyama, T., Hussien, T. A., Imagawa, H., Suenaga, M., … Hegazy, M. E. F. (2020). New isopimaradiene diterpenoids from kaempulchraol E via Rhizopus oryzae fungal transformation. Phytochemistry Letters, 38, 107–111. https://doi.org/10.1016/j.phytol.2020.05.006
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.